MA54322A - Polythérapies pour mds à haut et très haut risque - Google Patents
Polythérapies pour mds à haut et très haut risqueInfo
- Publication number
- MA54322A MA54322A MA054322A MA54322A MA54322A MA 54322 A MA54322 A MA 54322A MA 054322 A MA054322 A MA 054322A MA 54322 A MA54322 A MA 54322A MA 54322 A MA54322 A MA 54322A
- Authority
- MA
- Morocco
- Prior art keywords
- therapy
- risk mds
- mds
- risk
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
- A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862773490P | 2018-11-30 | 2018-11-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA54322A true MA54322A (fr) | 2021-10-06 |
Family
ID=70854408
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA054322A MA54322A (fr) | 2018-11-30 | 2019-11-26 | Polythérapies pour mds à haut et très haut risque |
Country Status (14)
Country | Link |
---|---|
US (1) | US20220016082A1 (fr) |
EP (1) | EP3886865A4 (fr) |
JP (1) | JP2022511746A (fr) |
KR (1) | KR20210097157A (fr) |
CN (1) | CN113412115A (fr) |
AU (1) | AU2019389004A1 (fr) |
BR (1) | BR112021010101A2 (fr) |
CA (1) | CA3121188A1 (fr) |
EA (1) | EA202191503A1 (fr) |
IL (1) | IL283464A (fr) |
MA (1) | MA54322A (fr) |
MX (1) | MX2021006127A (fr) |
SG (1) | SG11202105506UA (fr) |
WO (1) | WO2020112848A1 (fr) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8404716B2 (en) * | 2002-10-15 | 2013-03-26 | Celgene Corporation | Methods of treating myelodysplastic syndromes with a combination therapy using lenalidomide and azacitidine |
ES2774296T3 (es) * | 2012-10-30 | 2020-07-20 | Mei Pharma Inc | Terapias de combinación para tratar cánceres quimiorresistentes |
WO2016133910A1 (fr) * | 2015-02-17 | 2016-08-25 | Cantex Pharmaceuticals, Inc. | Traitement de cancers et de troubles de cellules souches hématopoïétiques privilégiés par interaction cxcl12-cxcr4 |
-
2019
- 2019-11-26 EP EP19891614.0A patent/EP3886865A4/fr not_active Withdrawn
- 2019-11-26 JP JP2021528453A patent/JP2022511746A/ja active Pending
- 2019-11-26 BR BR112021010101-2A patent/BR112021010101A2/pt not_active Application Discontinuation
- 2019-11-26 US US17/294,513 patent/US20220016082A1/en not_active Abandoned
- 2019-11-26 CA CA3121188A patent/CA3121188A1/fr active Pending
- 2019-11-26 WO PCT/US2019/063360 patent/WO2020112848A1/fr unknown
- 2019-11-26 MA MA054322A patent/MA54322A/fr unknown
- 2019-11-26 KR KR1020217019884A patent/KR20210097157A/ko unknown
- 2019-11-26 EA EA202191503A patent/EA202191503A1/ru unknown
- 2019-11-26 SG SG11202105506UA patent/SG11202105506UA/en unknown
- 2019-11-26 MX MX2021006127A patent/MX2021006127A/es unknown
- 2019-11-26 CN CN201980090984.8A patent/CN113412115A/zh active Pending
- 2019-11-26 AU AU2019389004A patent/AU2019389004A1/en not_active Abandoned
-
2021
- 2021-05-26 IL IL283464A patent/IL283464A/en unknown
Also Published As
Publication number | Publication date |
---|---|
JP2022511746A (ja) | 2022-02-01 |
BR112021010101A2 (pt) | 2021-08-24 |
KR20210097157A (ko) | 2021-08-06 |
WO2020112848A1 (fr) | 2020-06-04 |
IL283464A (en) | 2021-07-29 |
CA3121188A1 (fr) | 2020-06-04 |
EP3886865A1 (fr) | 2021-10-06 |
EP3886865A4 (fr) | 2022-11-23 |
SG11202105506UA (en) | 2021-06-29 |
CN113412115A (zh) | 2021-09-17 |
AU2019389004A1 (en) | 2021-07-15 |
US20220016082A1 (en) | 2022-01-20 |
MX2021006127A (es) | 2021-06-23 |
EA202191503A1 (ru) | 2021-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3303395T3 (da) | Anti-cd40-antistoffer og anvendelser deraf | |
FR3054466B3 (fr) | Centre d’usinage pour profiles metalliques | |
DK3645570T3 (da) | VISTA-antigenbindende molekyler | |
DK3441086T3 (da) | Monoklonalt anti-PD-1-antistof | |
DE112020002807A5 (de) | Kühlvorrichtung | |
GB201814562D0 (en) | Vista antigen-binding molecules | |
DK3348498T3 (da) | Drivsystem til transportører der kan forlænges | |
ITUB20160255A1 (it) | Apparato di saldatura | |
MA46858A (fr) | Réacteur à fusion | |
DK3537089T3 (da) | Køleapparat | |
MA45589A (fr) | Élévateur à ciseaux amélioré pour fauteuil roulant | |
DK3537334T3 (da) | Kamera | |
MA54322A (fr) | Polythérapies pour mds à haut et très haut risque | |
ITUA20163694A1 (it) | "ciclocomputer con dispositivo di elaborazione delle immagini" | |
FR3031341B1 (fr) | Ensemble propulsif pour aeronef | |
FR3032657B1 (fr) | Glissiere pour siege de vehicule et siege de vehicule comportant une telle glissiere | |
DK3512878T3 (da) | Bispecifik antistoffremvisning på fagoverflade | |
FR3055373B1 (fr) | Inducteur pour turbopompe et turbopompe | |
MA47065A (fr) | Sonotrode à canaux de refroidissement non linéaires | |
DK3791095T3 (da) | Proceskomponent | |
FI20165419A (fi) | Hissi | |
ITUA20162815A1 (it) | Procedimento di laminazione di fogli di alluminio e fogli di alluminio ottenuti con detto procedimento | |
FR3049751B1 (fr) | Perfectionnement pour accordeon | |
FR3033124B1 (fr) | Piquet metallique profile pour le palissage arboricole | |
FR3046351B1 (fr) | Chariot- portoir pour brancard. |